Correlation Between Kibush Capital and Pfizer

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Kibush Capital and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kibush Capital and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kibush Capital Corp and Pfizer Inc, you can compare the effects of market volatilities on Kibush Capital and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kibush Capital with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kibush Capital and Pfizer.

Diversification Opportunities for Kibush Capital and Pfizer

-0.3
  Correlation Coefficient

Very good diversification

The 3 months correlation between Kibush and Pfizer is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Kibush Capital Corp and Pfizer Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc and Kibush Capital is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kibush Capital Corp are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc has no effect on the direction of Kibush Capital i.e., Kibush Capital and Pfizer go up and down completely randomly.

Pair Corralation between Kibush Capital and Pfizer

Given the investment horizon of 90 days Kibush Capital Corp is expected to generate 19.54 times more return on investment than Pfizer. However, Kibush Capital is 19.54 times more volatile than Pfizer Inc. It trades about 0.1 of its potential returns per unit of risk. Pfizer Inc is currently generating about 0.21 per unit of risk. If you would invest  0.03  in Kibush Capital Corp on September 8, 2022 and sell it today you would earn a total of  0.00  from holding Kibush Capital Corp or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Kibush Capital Corp  vs.  Pfizer Inc

 Performance (%) 
       Timeline  
Kibush Capital Corp 
Kibush Performance
1 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Kibush Capital Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively uncertain fundamental indicators, Kibush Capital reported solid returns over the last few months and may actually be approaching a breakup point.

Kibush Price Channel

Pfizer Inc 
Pfizer Performance
5 of 100
Compared to the overall equity markets, risk-adjusted returns on investments in Pfizer Inc are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent technical and fundamental indicators, Pfizer may actually be approaching a critical reversion point that can send shares even higher in January 2023.

Pfizer Price Channel

Kibush Capital and Pfizer Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Kibush Capital and Pfizer

The main advantage of trading using opposite Kibush Capital and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kibush Capital position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.
Kibush Capital vs. ATT Inc
Kibush Capital vs. Fidelity MSCI Energy
Kibush Capital vs. Bondbloxx ETF Trust
Kibush Capital vs. Merck Company
The idea behind Kibush Capital Corp and Pfizer Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Pfizer vs. Johnson Johnson
Pfizer vs. The Boeing
Pfizer vs. Cisco Systems
Pfizer vs. Intel
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Volatility Analysis module to get historical volatility and risk analysis based on latest market data.

Other Complementary Tools

Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go